retatrutide news today october 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS investigation Retatrutide Availability & Timeline |

Continuing previous reports 6,47 , cold stress increased average daily food consumption in all genotypes and both sexes (Fig

Withdraw and confirm the dose counter shows zero

Novo Nordisk recently pulled out of a $10 billion bidding war with Pfizer for Metsera arguably an attempt to regain dominance in the lucrative obesity drug market through acquisition of further weight loss drug brands even though the treatments from Metsera could still be years away from hitting shelves

From injectable GLP and GLP-1 to needle-free oral GLP-1 plus Zofran for nausea support well help you find the right medical weight loss option